Fundamental analysis by بورس24 | Bourse24 about Stock دکیمی on 4/3/2024

Mehrabian, a member of the Kimidaro Board of Directors, emphasized in today's meeting: 🔹 #Dakimi branding needs to be strengthened and market share must be maintained. New drugs are coming to the market. The amount and type of production of some drugs has been monitored. 🔹competition in some products such as anti-diabetes has been tough so that it is considered the brand and specialized product of other companies. The liquidity problem has overshadowed the supply of raw materials. The increase in the rate of some products will show its effect in the next six months. @bourse24ir